Results 1 to 10 of about 16,062 (202)

Intravenous trimethoprim–sulfamethoxazole desensitization as a therapeutic strategy for late-onset Pneumocystis jirovecii pneumonia in a kidney transplant recipient: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Pneumocystis jirovecii pneumonia is a potentially fatal opportunistic infection in kidney transplant recipients under intensified immunosuppression.
Banu Yılmaz
doaj   +2 more sources

Pneumocystis jirovecii pneumonia: a case report. [PDF]

open access: yesJ Med Case Rep
Abstract Introduction and importance Pneumocystis jirovecii (PJP) pneumonia is a serious life-threatening condition in immunocompromised individuals and is often associated with human immunodeficiency virus (HIV) + patients.
Gri J, Jain V.
europepmc   +4 more sources

Advances in pathogen detection of <i>Pneumocystis jirovecii</i> pneumonia. [PDF]

open access: yesInfect Med (Beijing)
Pneumocystis jirovecii pneumonia (PJP) is a life-threatening opportunistic fungal infection in immunocompromised populations. Microscopic identification of P. jirovecii cysts or trophozoites in lower respiratory specimens remains the diagnostic gold standard.
Bai L, Li Y, Li Y, Hu C, Zhao B.
europepmc   +3 more sources

Pneumocystis jirovecii Pneumonia [PDF]

open access: yesInfectious Disease Clinics of North America, 2010
Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus ...
Catherinot, Emilie   +5 more
  +7 more sources

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients

open access: yesAvicenna Journal of Medicine, 2023
Pneumocystis jirovecii pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease.
Atif Ibrahim   +9 more
doaj   +1 more source

Successful treatment of severe pneumonia in a diffuse large B-cell lymphoma patient after R-CHOP chemotherapy: A case report

open access: yesSAGE Open Medical Case Reports, 2023
R-CHOP chemotherapy has been established as the first-line standard treatment for elderly patients diagnosed with diffuse large B-cell lymphoma. However, an increased risk of Pneumocystis jirovecii pneumonia in diffuse large B-cell lymphoma patients ...
Yan Xu   +4 more
doaj   +1 more source

Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
BackgroundPneumocystis jirovecii can result in a serious pulmonary infection, Pneumocystis jirovecii pneumonia, in immunocompetent hosts. The diagnosis of Pneumocystis jirovecii pneumonia has long been a major clinical concern, and there are limitations ...
Yangqing Zhan   +8 more
doaj   +1 more source

CONVENTIONAL METHODS FOR THE DIAGNOSIS OF PNEUMOCYSTIS JIROVECII IN IMMUNOCOMPROMISED IRAQI PATIENTS

open access: yesThe Iraqi Journal of Medical Sciences, 2016
Background: Pneumocystis jirovecii is the causative agent of pneumocystis pneumonia, one of the most frequent and severe opportunistic infections in immunocompromised patients.
Isa S. Touhali   +2 more
doaj   +6 more sources

Pneumocystis jirovecii pneumonia induced by low-dose methotrexate in a patient with chronic urticaria [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria. We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total
Sheng-Huei Wang   +4 more
doaj   +1 more source

Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. [PDF]

open access: yes, 2007
Co-trimoxazole (trimethoprim-sulfamethoxazole) is a widely available antibiotic that substantially reduces HIV-related morbidity and mortality in both adults and children.
Abdel-Haq   +33 more
core   +2 more sources

Home - About - Disclaimer - Privacy